B BRAUN MELSUNGAN AG in Cardiac Surgery Instruments

B Braun Melsungen AG is among the leading players in the cardiac surgery instruments market. The long-term presence of the company with its significant presence across major countries provides it with an additional edge over its competitors. To this end, it invested USD 170 million in 2013 to construct a new industrial park in Rio de Janeiro (Brazil), an emerging market for the healthcare industry. This park is intended to be a state-of-the-art manufacturing hub for various medical devices and surgical instruments. Moreover, to develop innovative medical and surgical instruments, the company continues to rely on R&D activities. Their R&D expense in 2016 was USD 323.5 million. Note: significant developments were reported by the company in the cardiac surgery instruments market between 2014 and 2017.